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Introduction: The clinical and pathological correlation between hand–foot–mouth disease 
(HFMD) and ocular complications has not yet been established. However, individual case 
reports indicate a trend that may be the emergence of a new burden of the previous self-limiting 
virus. This virus is particularly prevalent in childcare centers and poses an infectious disease 
risk for this workplace.
Objectives: The primary objective of this case report is to describe an unusual clinical record 
of a patient who developed central serous retinopathy while unwell with HFMD. Discussion of 
management strategies for this workplace, its staff, and visitors is also included.
Methods: This was an observational case report that was identified and reported retrospectively. 
For comparison, a search of the literature to identify similar ocular complications of HFMD 
was also undertaken. Results from this search, in addition to international data and prevention 
and management strategies are also provided.
Results: A total of 13 individual case reports with ocular associations, including this clinical 
record, were identified in the literature worldwide. The median age was 33 years, and three 
patients (23%) were female. No treatment or management guidelines for ocular complications 
of HFMD have been identified.
Conclusion: Severe and potentially life-threatening complications of a seemingly harmless 
childhood illness are represented sporadically in the literature. The requirement for research and 
evaluation into this emerging occupational hazard area is necessary for improved prevention, 
management, and treatment strategies to be developed.
Keywords: hand–foot–mouth disease, hand–foot–mouth, ocular complications, central serous 
retinopathy, childcare center
Background
Occupational exposure to infectious diseases is well described in the literature; however, 
specific considerations for hand–foot–mouth disease (HFMD) in childcare centers has 
limited evidence.1 With an estimated 473,000 children in formal child care in Australia, 
infectious disease risk for childcare workers is an important consideration.1 In addition, 
workplace exposure to visitors and carers of children attending childcare centers is a 
significant factor for disease transmission.1
Central serous retinopathy (CSR) is a chorioretinal disease of the eye that is charac-
terized by an accumulation of subretinal fluid in the posterior pole.2 Hyperpermeability 
of choroidal vessels and retinal pigment-epithelium dysfunction may also contribute to 
the disease’s etiology, and hypercortisolic states may play a role in triggering  episodes.2 
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This report presents a case in which a patient who after 
attending a childcare center initially presented with HFMD, 
then developed vision disturbance that was later diagnosed 
as CSR. The pathogenic connection between the two illnesses 
has limited evidence in the literature; however, this presents 
an unusual case for consideration.
Hand–foot–mouth disease
HFMD is a systemic viral illness that was discovered in 1969 
and is primarily caused by Coxsackie A16 and enterovirus 
71.3–5 Clinical features typically include fever, painful papules, 
and blisters over the extremities and genitalia and ulceration of 
the mouth, palate, and pharynx.3 HFMD can affect both adults 
and children; however, it is more common in children under 
the age of 10 years.6 This mild vesicular eruption occurs most 
commonly among groups of children in childcare centers, 
due to rapid transmission processes.6 HFMD is highly con-
tagious, with transmission occurring through oral respiratory 
secretions, touch contact with the blistered areas, fecal–oral 
transmission (most common), or from contaminated environ-
mental sources.4,6,7 The clinical course of HFMD is described 
in Box 1 and can be used to relate to the patient described 
in the case. The pathogenesis of HFMD involves enteroviral 
implantation in the gastrointestinal tract (buccal mucosa and 
ileum) with extension into the regional lymph nodes.4 Viremia 
occurs 72 hours later as a result of seeding of the oral mucosa 
and skin of the hands and feet.4
Clinical record
A 32-year-old male Caucasian refrigeration mechanic pre-
sented to his general practitioner with initial symptoms of 
severe sore throat (ulcerations visible), mild fever, malaise, 
and body aches. The patient was healthy, with no history of 
immunosuppression or smoking. The symptoms had been 
present for 36–48 hours upon presentation. The patient had a 
body mass index of 26. His personal history was significant: 
with an 18-month-old infant at home attending a childcare 
center 2 days per week. The patient regularly entered the 
childcare center to drop off and pick up his child. He had 
an unremarkable medical history, except childhood asthma 
and mild atopic associations. His ocular history indicated 
complete vision with no impairment in either eye.
The general practitioner initially diagnosed a bacterial 
throat infection and prescribed amoxicillin 500 mg three 
times daily for 5 days. Two days later, papular vesicles 
began to develop on the palms and soles of the feet 
( Figure 1). Four days after the initial onset of symptoms, the 
patient had developed extensive blisters extending beyond 
the palmar surfaces of hands and feet and onto the face, 
nasal cavity, ears, scalp, and buttocks. The patient rated 
the pain from the vesicles as 7/10 and required moderate 
pain management.
The patient also developed complete central visual field 
loss in one eye and mild visual disturbance in the other on 
day 6. He presented to the emergency department and was 
referred to the local optometrist for investigation. Physical 
examination was classic of features of HFMD and followed 
the expected clinical course to resolution of blisters, so sero-
logical testing was not indicated. Blood tests were baseline, 
mainly for liver function associated with virus, and normal, 
as expected with Coxsackie virus or HFMD.
Box 1 Clinical course of hand–foot–mouth disease
Incubation period 3–5 days
Initial fever, headache, and malaise
Sore throat and mouth
Vesicular rash develops after 1–2 days, beginning as a red macule and 
then progressing to vesicles
Vesicles present on hands, palms, and soles, and less commonly on 
limbs, buttocks, and genitals
Lesions resolve in 3–5 days and heal without scarring
Virus is excreted in feces and saliva for several weeks, and children 
are infectious until blisters have disappeared
Note: Data from Murtagh and Rosenblatt.6
Figure 1 Palmar-vesicle images.
Notes: (A) At 3 days after initial symptom presentation; (B) at 12 days after initial 
symptom presentation.
A
B
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Ophthalmic examination included visual acuity. The 
visual field was examined, which was not a valid exam, as 
visual acuity was low. Slit-lamp examination did not reveal 
any floaters or cells in the anterior chamber or any corneal 
abrasions on fluorescein staining. Optical coherence tomog-
raphy was conducted and reviewed by a visiting ophthal-
mologist. Figure 2 shows an optical coherence tomography 
retinal thickness map and horizontal high-resolution images 
of the right eye showing central serous chorioretinopathy. 
The ophthalmologist made a diagnosis of CSR and the senior 
medical officer diagnosed HFMD potentially associated with 
the CSR. The patient’s dermatological symptoms resolved 
over ~10 days; however, ocular symptoms improved but did 
not completely resolve. The patient’s vision in the right eye 
remains impaired, due to scarring, and no further improve-
ment is expected. He was referred to the ophthalmology clinic 
in a regional hospital.
Written informed consent was provided by the patient 
to have the case details and any accompanying images 
published. No institutional approval was required to publish 
this case report.
Discussion
HFMD epidemiology
HFMD is extremely transmissible, with infection rates of 
almost 100% in young children.8 In the past 20 years, this 
virus has been the main contributor to HFMD worldwide 
and been responsible for large outbreaks in Southeast Asia.7 
In Taiwan during 1998 and China during 2008–2010, there 
was an epidemic of enterovirus 71, during which ~500,000 
infections and 126 deaths were recorded for China.8 These 
epidemics were associated with central nervous system dis-
ease (eg, brain-stem encephalitis, seizures), myocarditis, and 
pulmonary hemorrhage.8 Deaths recorded were primarily for 
the age group of children <5 years.8
Australia and New Zealand have also reported outbreaks 
of HFMD in recent years; however, it is difficult to determine 
the frequency at which outbreaks may be occurring, as this 
disease is not notifiable to any public health unit.7,9 From 
December 2012 until May 2013, an epidemic of enterovirus 
17 occurred in Sydney.7 This outbreak resulted in 119 chil-
dren being admitted to a tertiary hospital with fever, lethargy, 
myoclonus, and skin rash.7 Of note, only 24% of the cases 
Figure 2 OCT retinal thickness map and horizontal high-resolution images of the right eye showing central serous chorioretinopathy.
Abbreviations: OCT, optical coherence tomography; ILM, internal limiting membrane; RPE, retinal pigment epithelium.
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presented with classical HFMD symptoms, and 30 presented 
with severe neurological symptoms.7,9
In the same reporting period, Auckland, New Zealand 
recorded 98 cases of presumed HFMD compared with 18 
cases in the previous year for this period.9 It was noted that 
the mouth ulcers and skin lesions were more widespread 
than typical HFMD, and nail shedding after the rash was 
frequently reported.9 One of these cases reported suspected 
encephalitis with laboratory-confirmed Coxsackie virus 
A6 involvement.9 It has been identified that the epidemic 
activity was associated with three specific lineages, two of 
which (B3 and B4) had not been described previously.5 These 
epidemics indicate that enterovirus 71 and Coxsackie A6 are 
likely to remain a public health concern for Australia, and 
surveillance and prevention strategies will be essential for 
effective management.7
HFMD complications
The literature presents a variety of atypical presentations and 
complications of HFMD. These presentations are provided in 
Table 1 and provide a summary of the unusual cases that have 
been reported.10–14 Although there have been individual case 
reports published, there is limited literature investigating whether 
HFMD is presenting in more severe cases than its previous mild 
self-limiting illness.11 In addition, there have been multiple case 
reports of immunocompetent adults contracting self-limiting 
HFMD from contact with young infected children.15–17
Ocular complications
Ocular complications, in particular central serous retinopa-
thies associated with HFMD, have been reported sporadically 
Table 1 Representation of atypical presentations and complications of HFMD reported in the literature
Author Patient 
age
Description Causative agent Atypical presentation/
complication
Feder et al11 9-month-old 
male
Vesiculobullous lesions extending over the whole body 
and onychomadesis on big toes
Confirmed 
Coxsackie virus A6
Vesiculobullous lesions 
and onychomadesis
Stewart et al14 37-year-old 
male
Widespread, crusted, pruritic papules on scalp, ears, and 
face and targetoid painful vesicular eruption on hands 
and feet with accompanying neurological symptoms and 
arthritis
Confirmed 
Coxsackie virus A6
Neurological symptoms 
and arthritis
Shikuma et al13 22-year-old 
male
Severe mucosal lesions with rapid erosion impairing the 
ability to consume food; immunocompetent adult
Suspected 
Coxsackie virus 16, 
not confirmed
Severe mucosal eroding 
lesions
Legey et al12 76-year-old 
male
Initial presentation of acute-onset fever, lumbar pain, and 
dyspnea; close contact with child with HFMD 1 week 
earlier
Confirmed 
Coxsackie virus A6
Fatal pneumonitis
Chatproedprai 
et al10
Eight 
children: 10 
months old 
to 12 years 
old
Large vesicles resembling varicella eruption, crust on 
scalp, widespread purpura-like lesions, Gianotti–Crosti 
syndrome, and desquamation
Various Unusual skin 
manifestations
Abbreviation: HFMD, head–foot–mouth disease.
in the literature, making this case report unique. In 2000, there 
was a case reported of monofocal outer retinitis associated 
with HFMD caused by Coxsackie virus in a healthy 36-year-
old male.18 Due to the close association between cutaneous 
eruption and the onset of visual symptoms, it was suggested 
that the retinal lesion was caused by Coxsackie virus B4 or 
B3.18 This case report aligns closely with the clinical record 
presented in this report.
Similarly, in 2015, a 35-year-old female presented with 
acute maculopathy with concurrent HFMD infection.19 
This patient had characteristic dermatological symptoms 
of HFMD and had been in contact with the virus from her 
daughter.19 Agrawal et al produced results from a system-
atic review of ocular associations of HFMD worldwide and 
identified 11 previous cases with a mean age of 33 years 
and only two occurring in females.19 The ocular morphology 
represented by these cases included chorioretinitis, vasculitis, 
exudates, macular detachment, retinitis, retinal detachment, 
and discoloration of the macula.19
Interestingly, none of the identified ocular complications 
associated with HFMD included CSR. Literature reporting 
on CSR has described the condition as rare and exacerbated 
by steroids and stress.20–22 CSR currently has no effective 
treatment available, but there is one case report of the use 
of topical nonsteroidal anti-inflammatory ointment that may 
have been useful in management, but as a single case, no 
definitive recommendations can be made.23
Prevention and management strategies
Outbreaks, severe disease, and case reports of spread of the 
disease to immunocompetent adults has prompted the WHO 
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to produce a guide for clinical management and public health 
response.24 It has been proposed that without intervention, the 
public health impact and spread of the disease will continue 
to intensify.24 Current measures being undertaken to prevent 
and control HFMD worldwide include improved surveillance, 
education on good hygiene and sanitation, assistance for 
childcare centers during outbreaks, strengthened infection-
control measures in communities and healthcare facilities, 
improved case management for patients presenting with 
severe illness or unusual symptoms, and monitoring and 
evaluation.24
As enterovirus 71 is not susceptible to any newly devel-
oped antiviral agents, the development of a vaccine for the 
future is also being considered.5,24 It is hoped that the develop-
ment of an effective live-attenuated vaccine would result in 
effective control of future epidemics.5 A formalin-inactivated 
enterovirus 71 vaccine have been developed and evaluated 
in human clinical trials.25 Although this vaccine was found 
to elicit full protection against enterovirus 71, it failed to 
prevent the Coxsackie A6 virus.25 As enterovirus 71 has been 
responsible for many outbreaks worldwide, this vaccine was 
being evaluated for effect in China in 2014, and government 
vaccination program decision makers are considering its use 
in practice.26
Improved emergency department surveillance and bet-
ter liaison with primary healthcare providers may improve 
the knowledge and management associated with this 
highly virulent disease.9 There is an urgent need to identify 
appropriate detection tools and best-practice guidelines to 
prevent transmission and effectively manage epidemics.27 
In a literature review conducted in 2017, control measures 
for HFMD epidemics included environmental disinfection, 
facility closure (between 6 and 30 days), promotion of per-
sonal or hand hygiene, isolation of symptomatic cases, body 
checks, and health education.27 Many of these measures are 
undertaken in child-care facilities currently; however, closure 
anecdotally does not occur, and the high virulence and rapid 
transmission makes the impact of control measures limited 
in the demographic of young children.27
Occupational prevention and 
management strategies
Child-care workers are exposed to a high prevalence of infec-
tious diseases through their close contact with children.1,28 
Job tasks, including physical care and personal hygiene, lead 
to exposure to biological hazards and infectious diseases.28,29 
In an effort to limit disease transmission and reduce work-
place exposure, a risk management process is essential for 
implementation in all child-care settings.26,30 The following 
strategies may be utilized to reduce infectious disease risk 
to children, child-care workers, and visitors to occupational-
childcare settings:
-	 robust hygiene measures (eg, hand washing, nappy 
changes)31
-	 adequate supplies of protective equipment (eg, gloves, 
face masks)31
-	 maintenance of an immunization register of all children 
and staff attending31
-	 adherence to policy guidelines for cleaning of all equip-
ment and surfaces31
-	 exclusion of staff and children presenting with signs of 
illness for the defined exclusion period26,31
-	 separating children in nappies from older children1
-	 providing timely communication to carers and staff of 
confirmed cases of infectious diseases31
Conclusion
It is evident that infectious diseases, particularly HFMD, have 
high prevalence in child-care settings, which places child-care 
workers and visitors to childcare centers at risk of disease 
transmission. From the case reported, it can be identified that 
seemingly self-limiting illnesses, such as HFMD, may have 
serious and potentially permanent impact. It can be noted 
that although literature demonstrating ocular complications 
of HFMD is limited, as the disease is not notifiable, many 
complications may be occurring worldwide without being 
reported.
Improved surveillance in both the primary care and 
emergency care settings would provide increased knowledge 
regarding the incidence, demographics, and occurrence 
of both atypical presentations and unusual complications. 
This information would allow for the development of robust 
guidelines to reduce severe illness, permanent disability, 
and death that is occurring from HFMD. Additionally, more 
data in this area may also result in improved prevention and 
management strategies being implemented in the workplace.
Disclosure
The authors report no conflicts of interest in this work.
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